Search research articles
Contact Us
Filters
Showing results (921-930 of 1,306) with videos related to
Page
of 131
Sort By:
Headache
|
August 15, 2019
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study
Richard B Lipton, Sagar Munjal, Dawn C Buse, et al.
Current Medical Research and Opinion
|
April 7, 2005
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians
R B Lipton, F M Cutrer, P J Goadsby, et al.
Cephalalgia : an International Journal of Headache
|
February 9, 2019
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study
David W Dodick, Michael L Reed, Kristina M Fanning, et al.
Headache
|
November 12, 2020
Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
Richard B Lipton, Joshua M Cohen, Kristen Bibeau, et al.
Journal of Medical Economics
|
May 5, 2022
Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials
Joshua Tobin, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
Alzheimer Disease and Associated Disorders
|
December 15, 2015
Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment: Results From the Einstein Aging Study
Mindy J Katz, Carol A Derby, Cuiling Wang, et al.
Neurology
|
November 2, 2014
Motoric cognitive risk syndrome: Multicenter incidence study
Joe Verghese, Emmeline Ayers, Nir Barzilai, et al.
Journal of Alzheimer'S Disease : JAD
|
June 25, 2016
Motoric Cognitive Risk Syndrome and Falls Risk: A Multi-Center Study
Michele L Callisaya, Emmeline Ayers, Nir Barzilai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Technology and Dementia Preconference
Angel Garcia De La Garza, Carol A Derby, Cuiling Wang, et al.
Pain and Therapy
|
April 17, 2026
Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial
Amaal J Starling, David Kudrow, Neha Kapur, et al.
Page
of 131
Search research articles
Search
Showing results (921-930 of 1,306) with videos related to
Sort By:
Page
of 131
Headache
|
August 15, 2019
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study
Richard B Lipton, Sagar Munjal, Dawn C Buse, et al.
Current Medical Research and Opinion
|
April 7, 2005
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians
R B Lipton, F M Cutrer, P J Goadsby, et al.
Cephalalgia : an International Journal of Headache
|
February 9, 2019
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study
David W Dodick, Michael L Reed, Kristina M Fanning, et al.
Headache
|
November 12, 2020
Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study
Richard B Lipton, Joshua M Cohen, Kristen Bibeau, et al.
Journal of Medical Economics
|
May 5, 2022
Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials
Joshua Tobin, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
Alzheimer Disease and Associated Disorders
|
December 15, 2015
Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment: Results From the Einstein Aging Study
Mindy J Katz, Carol A Derby, Cuiling Wang, et al.
Neurology
|
November 2, 2014
Motoric cognitive risk syndrome: Multicenter incidence study
Joe Verghese, Emmeline Ayers, Nir Barzilai, et al.
Journal of Alzheimer'S Disease : JAD
|
June 25, 2016
Motoric Cognitive Risk Syndrome and Falls Risk: A Multi-Center Study
Michele L Callisaya, Emmeline Ayers, Nir Barzilai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Technology and Dementia Preconference
Angel Garcia De La Garza, Carol A Derby, Cuiling Wang, et al.
Pain and Therapy
|
April 17, 2026
Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial
Amaal J Starling, David Kudrow, Neha Kapur, et al.
Page
of 131